Phio Pharmaceuticals Corp. (PHIO)
1.105
+0.02
(+1.38%)
USD |
NASDAQ |
Sep 01, 16:00
1.105
0.00 (0.00%)
After-Hours: 19:41
Phio Pharmaceuticals Total Long Term Debt (Quarterly) : 0.00 for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.035M |
| September 30, 2022 | 0.07M |
| June 30, 2022 | 0.104M |
| March 31, 2022 | 0.138M |
| December 31, 2021 | 0.17M |
| September 30, 2021 | 0.202M |
| June 30, 2021 | 0.234M |
| March 31, 2021 | 0.265M |
| December 31, 2020 | 0.526M |
| September 30, 2020 | 0.556M |
| June 30, 2020 | 0.585M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.383M |
| December 31, 2019 | 0.411M |
| September 30, 2019 | 0.438M |
| June 30, 2019 | 0.465M |
| March 31, 2019 | 0.50M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Imunon, Inc. | 5.914M |
| Agenus, Inc. | 259.00M |
| Amgen, Inc. | 57.30B |
| Anika Therapeutics, Inc. | 23.32M |
| BioCryst Pharmaceuticals, Inc. | 834.73M |